Steward Partners Investment Advisory
HRMY icon

Steward Partners Investment Advisory’s Harmony Biosciences HRMY Stock Holding History

Steward Partners Investment Advisory’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-170
Closed -$4.76K – 4760
2026
Q1 		$4.76K Hold
170
– – ﹤0.01% 3815
2025
Q4 		$6.36K Hold
170
– – ﹤0.01% 3614
2025
Q3 		$4.68K Hold
170
– – ﹤0.01% 3677
2025
Q2 		$5.37K Hold
170
– – ﹤0.01% 3455
2025
Q1 		$5.64K Hold
170
– – ﹤0.01% 3344
2024
Q4 		$5.85K Hold
170
– – ﹤0.01% 3308
2024
Q3 		$6.8K Buy
+170
New +$5.97K ﹤0.01% 3094

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Armistice Capital
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Steward Partners Investment Advisory's HRMY Position: Q2 2026 in Review

Steward Partners Investment Advisory sold out of Harmony Biosciences (HRMY) in Q2 2026, closing a stake of 170 shares — an estimated $4.76K sold.

Steward Partners Investment Advisory first reported a position in HRMY in Q3 2024 and held it in 7 quarters. The position peaked at $6.8K in Q3 2024. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Steward Partners Investment Advisory reported no remaining Harmony Biosciences position as of Q2 2026 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 170 Harmony Biosciences shares in Q2 2026, an estimated $4.76K.
  • Steward Partners Investment Advisory first reported a position in Harmony Biosciences in Q3 2024 and held it in 7 quarters.
  • Steward Partners Investment Advisory's Harmony Biosciences position peaked at $6.8K in Q3 2024.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.